189
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Smoking history and emphysema in asthma–COPD overlap

, , , , , & show all
Pages 3523-3532 | Published online: 07 Dec 2017

References

  • SorianoJBDavisKJColemanBVisickGManninoDPrideNBThe proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United KingdomChest2003124247448112907531
  • MarshSETraversJWeatherallMProportional classifications of COPD phenotypesThorax200863976176718728201
  • WeatherallMTraversJScirtcliffePMDistinct clinical phenotypes of airways disease defined by cluster analysisEur Respir J200934481281819357143
  • Global Initiative for AsthmaGlobal strategy for asthma management and prevention Updated 2017. Available from: http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/Accessed May 1, 2017
  • GibsonPGSimpsonJLThe overlap syndrome of asthma and COPD: what are its features and how important is it?Thorax200964872873519638566
  • SinDDMiravitllesMManninoDMWhat is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussionEur Respir J201648366467327338195
  • HardinMSilvermanEKBarrRGCOPDGene InvestigatorsThe clinical features of the overlap between COPD and asthmaRespir Res20111212721951550
  • MeyerPAManninoDMReddSCOlsonDRCharacteristics of adults dying with COPDChest200212262003200812475839
  • HospersJJPostmaDSJijckenBWeiseSTSchoutenJPHistamine airway hyper-responsiveness and mortality from chronic pulmonary disease: a cohort studyLancet200035692381313131711073020
  • SilvaGESherrillDLGuerraSBarbeeRAAsthma as a risk factor for COPD in a longitudinal studyChest20041261596515249443
  • TashkinDPAltoseMDConnettJEKannerRELeeWWWiseRAMethacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive disease. The Lung Health Study Research GroupAm J Respir Crit Care Med19961536 Pt 1180218118665038
  • KurashimaKFukudaCNakamotoKCT-diagnosed emphysema and prognosis of chronic airflow obstruction: a retrospective studyBMJ Open2013311e003541
  • CosioBGSorianoJBLópez-CamposJLCHAIN StudyDefining the asthma-COPD overlap syndrome in a COPD cohortChest20161491455226291753
  • KurashimaKTakayanagiNSatoNHigh resolution CT and bronchial reversibility test for diagnosing COPDRespirology200510331632215955144
  • The Japanese Respiratory SocietyGuidelines for the Diagnosis and Treatment of COPD3rd edTokyoMedical Review Co., Ltd2013
  • SuzukiTTadaYKawataNClinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndromeInt J Chron Obstruct Pulmon Dis20151094795426028967
  • SuzukiMMakitaHKonnoSHokkaido COPD Cohort Study InvestigatorsAsthma-like features and clinical course of COPD: an analysis from the Hokkaido COPD Cohort StudyAm J Respir Crit Care Med2016194111358136527224255
  • BrightlingCEMonterioWWardRSputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomized controlled trialLancet200035692401480148511081531
  • BrightlingCEMcKennaSHargadonBSputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary diseaseThorax200560319319815741434
  • LeighRPizzichiniMMMorrisMMMaltaisFHargreaveFEPizzichiniEStable COPD: predicting benefit from high-dose inhaled corticosteroid treatmentEur Respir J200627596497116446316
  • FattahiFten HackenNHLöfdahlCGAtopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP studyRespir Res2013141023356508
  • PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomized controlled trialsLancet Respir Med20153643544225878028
  • TakakuYKurashimaKOhtaCHow many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?Respir Med201712311011528137486
  • BhattSPSierenJCDransfieldMTCOPDGene InvestigatorsComparison of spirometric thresholds in diagnosing smoking related airflow obstructionThorax201469540941423525095
  • Sanchez-SalcedoPZuluetaJJLung cancer in chronic obstructive pulmonary disease patients, it is not just the cigarette smokeCurr Opin Pulm Med201622434434927077725
  • OelsnerECCarrJJEnrightPLPer cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort studyThorax201671762463227048196
  • HenschkeCIYipRBoffettaPI-ELCAP InvestigatorsCT screening for lung cancer: importance of emphysema for never smokers and smokersLung Cancer2015881424725698134
  • ZaynagetdinovRSherrillTPGleavesLAChronic NF-kB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungsOncotarget2016755470548226756215
  • MacKenzieREckhardtJPrastyaniAWJapan tobacco international: to ‘be the most successful and respected tobacco company in the world’Glob Public Health201712328129928139966
  • SasakiHSekizawaKYanaiMAraiHYamayaMOhruiTEffects of air pollution and smoking on chronic obstructive pulmonary disease and bronchial asthmaTohoku J Exp Med1998186315116710348212
  • ChubachiSSatoMKameyamaNKeio COPD Comorbidity Research (K-CCR) GroupIdentification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohortRespir Med201611727227927492541
  • BhattSPWellsJMKinneyGLCOPDGene Investigatorsβ-Blockers are associated with a reduction in COPD exacerbationsThorax201671181426283710
  • LaforestLRocheNDevouassouxGFrequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: a population-base cohort studyRespir Med2016117333927492511